InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Serina Therapeutics, Inc.

SER Clue Score38
United States Fiscal year ends December CIK 0001708599
$2.00 -0.50% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.00 +117.39% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Nov 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue1.4Operating income−6.7Net income−6.6Fiscal year 2018Revenue1.4 −0.6%Operating income−11.2Net income−7.5Fiscal year 2019Revenue1.7 +23.8%Operating income−12.6Net income−12.2Fiscal year 2020Revenue0.4 −79.1%Operating income−10.1Net income−10.9Fiscal year 2021Revenue0.1 −60.1%Operating income−7.9Net income−8.7Fiscal year 2022Revenue0.0 −76.4%Operating income−7.0Net income−10.5EPS, diluted−9.70Fiscal year 2023Revenue3.2 +9,173.5%Operating income−3.1Net income5.3EPS, diluted0.73Fiscal year 2024Revenue0.1 −98.2%Operating income−17.0Net income−11.1 −311.4%EPS, diluted−1.51Fiscal year 2025Revenue0.1 +132.1%Operating income−24.0Net income−19.2EPS, diluted−1.91
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.4 1.4 1.7 0.4 0.1 0.0 3.2 0.1 0.1
Growth −0.6% +23.8% −79.1% −60.1% −76.4% +9,173.5% −98.2% +132.1%
Operating income −6.7 −11.2 −12.6 −10.1 −7.9 −7.0 −3.1 −17.0 −24.0
Net income −6.6 −7.5 −12.2 −10.9 −8.7 −10.5 5.3 −11.1 −19.2
Growth −311.4%
EPS, diluted n/a n/a n/a n/a n/a −9.70 0.73 −1.51 −1.91

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin88.0%Operating margin−474.6%Net margin−468.7%Free cash flow margin−447.7%Fiscal year 2018Gross margin73.9%Operating margin−805.5%Net margin−537.4%Free cash flow margin−574.2%Fiscal year 2019Gross margin85.9%Operating margin−726.8%Net margin−703.4%Free cash flow margin−625.1%Fiscal year 2020Gross margin92.8%Operating margin−2,797.8%Net margin−3,009.7%Free cash flow margin−2,170.9%Fiscal year 2021Gross margin86.8%Operating margin−5,509.0%Net margin−6,024.3%Fiscal year 2022Gross margin61.8%Operating margin−20,514.7%Net margin−30,770.6%Fiscal year 2023Gross margin3.2%Operating margin−99.2%Net margin167.1%Free cash flow margin−94.5%Fiscal year 2024Operating margin−30,442.9%Net margin−19,894.6%Free cash flow margin−30,641.1%Fiscal year 2025Operating margin−18,478.5%Net margin−14,755.4%Free cash flow margin−13,856.9%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 88.0% 73.9% 85.9% 92.8% 86.8% 61.8% 3.2% n/a n/a
Operating margin −474.6% −805.5% −726.8% −2,797.8% −5,509.0% −20,514.7% −99.2% −30,442.9% −18,478.5%
Net margin −468.7% −537.4% −703.4% −3,009.7% −6,024.3% −30,770.6% 167.1% −19,894.6% −14,755.4%
Free cash flow margin −447.7% −574.2% −625.1% −2,170.9% n/a n/a −94.5% −30,641.1% −13,856.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−6.3Capital expenditure−0.0Free cash flow−6.3Fiscal year 2018Operating cash flow−8.0Capital expenditure−0.0Free cash flow−8.0Fiscal year 2019Operating cash flow−10.2Capital expenditure−0.6Free cash flow−10.8Fiscal year 2020Operating cash flow−7.8Capital expenditure−0.0Free cash flow−7.8Fiscal year 2021Operating cash flow−7.9Fiscal year 2022Operating cash flow−5.9Fiscal year 2023Operating cash flow−2.5Capital expenditure−0.5Free cash flow−3.0Fiscal year 2024Operating cash flow−17.1Capital expenditure−0.0Free cash flow−17.2Fiscal year 2025Operating cash flow−18.0Capital expenditure−0.1Free cash flow−18.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.3 −8.0 −10.2 −7.8 −7.9 −5.9 −2.5 −17.1 −18.0
Capital expenditure −0.0 −0.0 −0.6 −0.0 n/a n/a −0.5 −0.0 −0.1
Free cash flow −6.3 −8.0 −10.8 −7.8 n/a n/a −3.0 −17.2 −18.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash7.4Shareholders’ equity7.3Fiscal year 2018Cash6.7Shareholders’ equity7.4Fiscal year 2019Cash2.4Shareholders’ equity2.2Fiscal year 2020Cash0.5Shareholders’ equity−5.1Fiscal year 2021Cash0.6Total debt13.2Net cash (debt)−12.6Shareholders’ equity−11.8Fiscal year 2022Cash0.6Total debt18.1Net cash (debt)−17.5Shareholders’ equity−17.2Fiscal year 2023Cash7.6Shareholders’ equity−32.3Fiscal year 2024Cash3.7Shareholders’ equity0.6Fiscal year 2025Cash3.1Shareholders’ equity−0.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.4 6.7 2.4 0.5 0.6 0.6 7.6 3.7 3.1
Total debt n/a n/a n/a n/a 13.2 18.1 n/a n/a n/a
Net cash (debt) n/a n/a n/a n/a −12.6 −17.5 n/a n/a n/a
Shareholders’ equity 7.3 7.4 2.2 −5.1 −11.8 −17.2 −32.3 0.6 −0.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.4 1.4 1.7 0.4 0.1 0.0 3.2 0.1 0.1
Growth −0.6% +23.8% −79.1% −60.1% −76.4% +9,173.5% −98.2% +132.1%
0.2 0.4 0.2 0.0 0.0 0.0 0.0 n/a n/a
1.2 1.0 1.5 0.3 0.1 0.0 0.1 n/a n/a
Growth −16.5% +43.8% −77.4% −62.7% −83.2% +385.7%
5.8 5.8 5.9 3.7 1.5 1.0 2.4 7.5 13.2
3.9 5.6 8.1 6.7 6.7 6.0 3.9 9.6 11.0
−6.7 −11.2 −12.6 −10.1 −7.9 −7.0 −3.1 −17.0 −24.0
Growth
n/a −7.7 −12.2 −11.1 8.7 10.5 5.3 −11.2 −19.2
n/a n/a 0.1 −0.2 n/a n/a 0.0 0.0 0.0
−6.6 −7.5 −12.2 −10.9 −8.7 −10.5 5.3 −11.1 −19.2
Growth −311.4%
Per share
n/a n/a n/a n/a −0.23 −9.70 2.36 −1.51 −1.91
n/a n/a n/a n/a n/a −9.70 0.73 −1.51 −1.91
Growth −306.8%
n/a n/a n/a n/a 37.9 0.0 2.2 7.4 10.2
n/a n/a n/a n/a n/a 0.0 7.4 7.4 10.2
Growth +681,179.0% +0.1% +38.5%

† The diluted share count jumps at 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 18.5% a year over five years.
  • Operating margin is down 15,680.7 points on five years ago, at -18,478.5%.
  • A net loss in 8 of 9 years on file.